Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in elderly people is usually mild and responds well to treatment.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Exosomes may help with hair growth and scar healing, but more research is needed.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The gene p53 is crucial for removing damaged cells to allow for healthy tissue renewal.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Cord blood platelets may have promising future medical uses but need more research.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.